APRIL WEAVER: Open Payments
NPI 1194300426 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 14 payments from 8 companies in 2025. Trend: 2023 $1,407 · 2024 $1,221 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $123 |
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| PFIZER INC. | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $14 |
Products named: REPATHA, LEQVIO, VERQUVO, VYNDAQEL, OPSUMIT, Assure WCD, Wegovy, LifeVest.
Industry payments across AZ — which companies pay providers there.
